HCW Biologics (HCWB) Revenue & Revenue Breakdown
HCW Biologics Revenue Highlights
Latest Revenue (Y)
$2.84M
Latest Revenue (Q)
$426.42K
HCW Biologics Revenue by Period
HCW Biologics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.84M | -57.72% |
| 2022-12-31 | $6.72M | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2020-12-31 | $4.10M | 100.00% |
| 2019-12-31 | - | - |
HCW Biologics generated $2.84M in revenue during NA 2023, up -57.72% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
HCW Biologics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $426.42K | -31.09% |
| 2024-06-30 | $618.85K | -45.07% |
| 2024-03-31 | $1.13M | -14.90% |
| 2023-12-31 | $1.32M | 55.20% |
| 2023-09-30 | $853.10K | 36.98% |
| 2023-06-30 | $622.81K | 1387.02% |
| 2023-03-31 | $41.88K | -96.88% |
| 2022-12-31 | $1.34M | -25.84% |
| 2022-09-30 | $1.81M | 298.46% |
| 2022-06-30 | $454.00K | -85.44% |
| 2022-03-31 | $3.12M | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $4.10M | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
HCW Biologics generated $426.42K in revenue during Q3 2024, up -31.09% compared to the previous quarter, and up 68.47% compared to the same period a year ago.
HCW Biologics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MOLN | Molecular Partners | $7.04M | $2.74M |
| HCWB | HCW Biologics | $2.84M | $426.42K |
| IPSC | Century Therapeutics | $2.23M | $791.00K |
| STTK | Shattuck Labs | $1.66M | $1.61M |
| MNOV | MediciNova | $1.00M | - |
| ANEB | Anebulo Pharmaceuticals | - | - |
| RZLT | Rezolute | - | - |
| PHVS | Pharvaris | - | - |
| PMVP | PMV Pharmaceuticals | - | - |
| PEPG | PepGen | - | - |
| CSBR | Champions Oncology | - | $-14.06M |